Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

This study has been terminated.

Study NCT00038376 Information provided by M.D. Anderson Cancer Center

First Received: May 30, 2002 Last Updated: March 12, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2005
Primary Completion Date:	June 2005 (Final data collection date for primary outcome measure)